Inclusion criteria • Female patients with breast cancer without distant metastases • WHO performance scale 0–2 • Treated with curative intent (i.e. lumpectomy or mastectomy, with or without radiotherapy and/or chemotherapy) • Treatment completed < 6 weeks prior to randomisation • Able to speak and read fluently in Dutch | |
Exclusion criteria • Participation in another trial, requiring more frequent follow-up • Medical diseases (treatment-related side-effects, concomitant tumours) requiring frequent follow-up |